Acute renal failure and its risk factors in stevens-johnson syndrome and toxic epidermal necrolysis

American Journal of Nephrology

Volumn 29, Issue 6, 2009, Pages 633-638

  Hung, Chi Chih ^a   Liu, Wan Chun ^a   Kuo, Mei Chuan ^a   Lee, Chih Hung ^a   Hwang, Shang Jyh ^a   Chen, Hung Chun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute interstitial nephritis; Acute renal failure; Erythema multiforme; Hypersensitivity

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; CARBAMAZEPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN;

ACUTE KIDNEY FAILURE; ADULT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPOALBUMINEMIA; HYPOKALEMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPSIS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADULT; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STEVENS-JOHNSON SYNDROME; WATER-ELECTROLYTE BALANCE;

EID: 58249130423     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000195632     Document Type: Review

References (20)

1. Roujeau JC: Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209:123-129.
2. Clarkson MR, Giblin L, O'Connell FP, O'Kelly P, Walshe JJ, Conlon P, O'Meara Y, Dormon A, Campbell E, Donohoe J: Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 2004;19:2778-2783.
3. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT: HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005;102:4134-4139.
4. Spanou Z, Keller M, Britschgi M, Yawalkar N, Fehr T, Neuweiler J, Gugger M, Mohaupt M, Pichler WJ: Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol 2006;17:2919-2927.
5. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC: Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002;138: 1019-1024.
6. Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De SC, Parodi A, Barletta E, Fabbri P: The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/ toxic epidermal necrolysis spectrum. Br J Dermatol 2006;154:319-324.
7. Hsu SI: Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy 2001;21:1233-1239.
8. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P: SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-153.
9. Wolkenstein P, Revuz J: Drug-induced severe skin reactions. Incidence, management and prevention. Drug Saf 1995;13:56-68.
10. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-96.
11. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
12. Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC: Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J 2005;35: 188-190.
13. Dreisbach AW, Lertora JJ: The effect of chronic renal failure on hepatic drug metabolism and drug disposition. Semin Dial 2003;16:45-50.
14. Liano F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998;66:S16-S24.
15. Yegenaga I, Hoste E, Van BW, Vanholder R, Benoit D, K a nt a rci G, Dhondt A , C ol a rdy n F, Lameire N: Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis 2004;43:817-824.
16. Yeung CK, Ma SY, Hon C, Peiris M, Chan HH: Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital. Acta Derm Venereol 2003;83:179-182.
17. Chan HL: Toxic epidermal necrolysis in Singapore, 1989 through 1993: incidence and antecedent drug exposure. Arch Dermatol 1995;131:1212-1213.
18. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.
19. Krauss G: Current understanding of delayed anticonvulsant hypersensitivity reactions. Epilepsy Curr 2006;6:33-37.
20. Adrogue HJ, Madias NE: Hyponatremia. N Engl J Med 2000;342:1581-1589.